Published in Methods Mol Biol on January 01, 2009
Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy. PLoS One (2015) 1.67
Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm. PLoS One (2015) 1.58
CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selection. J Bacteriol (2011) 1.54
Characterization of a ViI-like phage specific to Escherichia coli O157:H7. Virol J (2011) 1.16
The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages. PLoS One (2013) 1.00
Characterization of a P1-like bacteriophage carrying an SHV-2 extended-spectrum β-lactamase from an Escherichia coli strain. Antimicrob Agents Chemother (2014) 0.93
Isolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite Decontaminant. PLoS One (2015) 0.90
Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca. Curr Microbiol (2012) 0.89
Complete Genome Sequences of T4-Like Bacteriophages RB3, RB5, RB6, RB7, RB9, RB10, RB27, RB33, RB55, RB59, and RB68. Genome Announc (2015) 0.89
A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections. Sci Rep (2016) 0.87
Microplate-test for the rapid determination of bacteriophage-susceptibility of Campylobacter isolates-development and validation. PLoS One (2013) 0.84
In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients. Appl Microbiol Biotechnol (2015) 0.83
Bacteriophage Procurement for Therapeutic Purposes. Front Microbiol (2016) 0.82
Characterization of a novel Achromobacter xylosoxidans specific siphoviruse: phiAxp-1. Sci Rep (2016) 0.81
Prevalence, genetic diversity, and host range of tectiviruses among members of the Bacillus cereus group. Appl Environ Microbiol (2014) 0.80
Incomplete LPS Core-Specific Felix01-Like Virus vB_EcoM_VpaE1. Viruses (2015) 0.79
Phage therapy: eco-physiological pharmacology. Scientifica (Cairo) (2014) 0.78
Characterization of novel Staphylococcus aureus lytic phage and defining their combinatorial virulence using the OmniLog® system. Bacteriophage (2016) 0.77
Isolation and molecular characterisation of Achromobacter phage phiAxp-3, an N4-like bacteriophage. Sci Rep (2016) 0.76
In silico analysis of AHJD-like viruses, Staphylococcus aureus phages S24-1 and S13', and study of phage S24-1 adsorption. Microbiologyopen (2014) 0.76
Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes. Sci Rep (2016) 0.75
Characterization and complete genome of the virulent Myoviridae phage JD007 active against a variety of Staphylococcus aureus isolates from different hospitals in Shanghai, China. Virol J (2017) 0.75
Identification and molecular characterization of bacteriophage phiAxp-2 of Achromobacter xylosoxidans. Sci Rep (2016) 0.75
The Effectiveness of Bacteriophages against Methicillin-Resistant Staphylococcus aureus ST398 Nasal Colonization in Pigs. PLoS One (2016) 0.75
The First Siphoviridae Family Bacteriophages Infecting Bordetella bronchiseptica Isolated from Environment. Microb Ecol (2016) 0.75
Isolation, Characterization, and Bioinformatic Analyses of Lytic Salmonella Enteritidis Phages and Tests of Their Antibacterial Activity in Food. Curr Microbiol (2016) 0.75
Characterization of vB_SauM-fRuSau02, a Twort-Like Bacteriophage Isolated from a Therapeutic Phage Cocktail. Viruses (2017) 0.75